🇺🇸 FDA
Patent

US 10273233

Inhibitors of influenza viruses replication

granted A61KA61K31/4965A61K31/506

Quick answer

US patent 10273233 (Inhibitors of influenza viruses replication) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/4965, A61K31/506, A61K45/06, A61P